SCHEMBL6408318

SCHEMBL6408318

CCOC(=O)C1C(COCc2ccc(OC)cc2)C1(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.42
KMT2A Q03164 2/20 0.42
TSHR P16473 2/20 0.42
MEN1 O00255 1/20 0.42
GLA P06280 1/20 0.41
KDM4E B2RXH2 2/20 0.41
HPGD P15428 2/20 0.41
MMP1 P03956 1/20 0.40
MMP2 P08253 1/20 0.40
MMP3 P08254 1/20 0.40
MMP9 P14780 1/20 0.40
MMP13 P45452 1/20 0.40
GAA P10253 2/20 0.40
LMNA P02545 1/20 0.40
HSD17B10 Q99714 1/20 0.40
FABP7 O15540 1/20 0.39
FABP5 Q01469 1/20 0.39
TBXAS1 P24557 5/20 0.39
HTT P42858 1/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6407683 0.88 MMP1 (0.44) ALDH1A1MMP1MMP2MMP3MMP9
SCHEMBL29879710 0.86 ALDH1A1 (0.41) ALDH1A1KMT2ATSHRMEN1GLA
SCHEMBL29302282 0.86 ALDH1A1 (0.41) ALDH1A1KMT2ATSHRMEN1GLA
SCHEMBL1153506 0.86 TP53 (0.43) ALDH1A1TSHRKDM4ELMNAHTT
SCHEMBL6406010 0.84 MMP1 (0.45) ALDH1A1MMP1MMP2MMP3MMP9
SCHEMBL6408893 0.84 L3MBTL1 (0.41) ALDH1A1KMT2AMEN1MMP1MMP2
SCHEMBL6406994 0.84 ATM (0.42) ALDH1A1TSHR
SCHEMBL6474364 0.82 ALDH1A1 (0.49) ALDH1A1KMT2ATSHRMEN1KDM4E
SCHEMBL6406894 0.81 CACNA1B (0.43) ALDH1A1KMT2ATSHRHPGDMMP1
SCHEMBL2128100 0.79 FABP7 (0.48) ALDH1A1MMP1MMP2MMP9FABP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288526-A1 Process for production of 2-(hydroxymethyl)cyclo-propanecarboxylic acids SUMITOMO CHEMICAL COMPAY LIMTED (JP) 2005-12-29 US disclosed
EP-1538141-A1 PROCESS FOR PRODUCTION OF 2-(HYDROXYMETHYL)CYCLO- PROPANECARBOXYLIC ACIDS Sumitomo Chemical Company, Limited (JP) 2005-06-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288526-A1 Process for production of 2-(hydroxymethyl)cyclo-propanecarboxylic acids GRHPR, PCCA, C5 ALDH1A1 601/4885KMT2A 586/4885TSHR 1466/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.